iifl-logo
iifl-logo

Fresenius Kabi Oncology Ltd Share Price Live

₹752
(467.55%)
Jan 14, 2016|11:19:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Fresenius Kabi Oncology Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

₹753

Prev. Close

₹132.5

Turnover(Lac.)

₹0.23

Day's High

₹753

Day's Low

₹742.5

52 Week's High

₹0

52 Week's Low

₹0

Book Value

₹0

Face Value

₹1

Mkt Cap (₹ Cr.)

11,898.72

P/E

38.28

EPS

3.46

Divi. Yield

0

Fresenius Kabi Oncology Ltd Corporate Action

No Record Found

Fresenius Kabi Oncology Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center

Demat Account

View More

Trading Account

View More

Fresenius Kabi Oncology Ltd SHAREHOLDING SNAPSHOT

29 Jun, 2025|09:06 PM
Sep-2013Jun-2013Mar-2013Dec-2012
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 810.00%

Foreign: 81.00%

Indian: 0.00%

Non-Promoter- 10.93%

Institutions: 10.92%

Non-Institutions: 8.07%

Custodian: 0.00%

Read More
Share Price

Fresenius Kabi Oncology Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

53.81

52.84

51.86

16.52

Preference Capital

0

0

0

0

Reserves

1,281.43

1,226.9

1,178.83

42.01

Net Worth

1,335.24

1,279.74

1,230.69

58.53

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2019Mar-2018Mar-2017Mar-2016

Revenue

659.56

703.47

624.01

541.56

yoy growth (%)

-6.24

12.73

15.22

16.67

Raw materials

-269.23

-273.59

-258.59

-241.67

As % of sales

40.82

38.89

41.44

44.62

Employee costs

-143.47

-143.2

-124.42

-115.6

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2019Mar-2018Mar-2017Mar-2016

Profit before tax

40.89

58.55

10.68

-80.33

Depreciation

-54.62

-54.83

-48.7

-52.1

Tax paid

7.4

1.15

-4.56

16.33

Working capital

-64.6

1.14

120

-2.06

Other operating items

View Cash Flow
Y/e 31 MarMar-2019Mar-2018Mar-2017Mar-2016

Growth matrix (%)

Revenue growth

-6.24

12.73

15.22

16.67

Op profit growth

-30.73

47.93

-845.2

-86.64

EBIT growth

-25.21

118.5

-192.55

-58.99

Net profit growth

-375.33

-910.65

-97.07

-47.41

View Ratios
Particulars (Rupees in Crores.)Mar-2011Mar-2010Mar-2009Mar-2008Mar-2007

Gross Sales

530.78

490.26

318.41

278.25

326.73

Excise Duty

13.36

11.02

11.14

9.42

13.65

Net Sales

517.4

479.23

307.26

268.82

313.07

Other Operating Income

8.98

9.27

4.98

13.77

0

Other Income

3.74

14.43

17.2

125.36

12.73

View Annually Results

Fresenius Kabi Oncology Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,669.8

93.524,00,520.992,000.460.967,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,616

79.481,75,574.286670.452,536561.08

Cipla Ltd

CIPLA

1,513.8

25.391,22,1861,485.41.064,254.47397.41

Dr Reddys Laboratories Ltd

DRREDDY

1,321.5

20.611,10,263.531,200.70.615,546.3345.76

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,222.5

57.291,09,167.444740.992,385224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

View All Peer Comparision

MORE ABOUT Fresenius Kabi Oncology Ltd

Management

Register Office

Registrar Office

Director

Rakesh Bhargava

Director

Rajiv Lochan Jain

Director

Michael Schonhofen

Director

Uday Chandrashekhar Shetty

Director

Maria Gobbi

Company Secretary

Nikhil Kulshreshtha

Whole-time Director

Nikhil Kulshreshtha

Director

Steffen Georg Roser

Director

Karsten Peter Lerch

Managing Director

Arvind Kumar Sharma

Chief Financial Officer

Sandeep Kumar Chotia

Registered Office

B-310 Som Datt Chambers-I,

Bhikaji Cama Place,

New Delhi - 110066

Tel: 91-11-26105570

Website: http://www.fresenius-kabi-oncology.com

Email: [email protected]

Registrar Office

Narang Tower,

44 Community Centre, Naraina Ind Area,

New Delhi-110028

Tel: 91-11-41410592-94

Website: www.linkintime.co.in

Email: [email protected]

Summary

Fresenius Kabi Oncology Ltd (formerly known as Dabur Pharma Ltd) is a leading Indian company for cancer research and anticancer products. The company develops, manufactures and markets speciality phar...
Read More

Reports by Fresenius Kabi Oncology Ltd

QUICKLINKS FOR Fresenius Kabi Oncology Ltd

Information
Share PriceFutures PriceOption ChainHistorical Data
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Market
Derivatives
IPO
Mutual Funds
Calculators
Nifty 50
Company
Loans
Knowledge Center
News
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
For Investors

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.